Document Detail


Hypercoagulability in relation to coronary artery bypass graft patency and clinical outcome.
MedLine Citation:
PMID:  23205579     Owner:  NLM     Status:  Publisher    
Abstract/OtherAbstract:
Abstract Objective Hypercoagulability evaluated with thrombelastography (TEG) has been reported to be associated to thrombembolic events in patients undergoing coronary artery bypass graft surgery (CABG). The objective of this study was to test the hypothesis that graft patency and post-CABG thrombembolic events are related to the pre-surgical TEG status. Design 124 patients scheduled for CABG were matched according to mean age, gender and mean left ventricular ejection fraction in two groups defined by their pre-surgical TEG status (TEG-hypercoagulable and TEG-normocoagulable). Three months after the operation graft patency was assessed with multidetector computed tomography (MDCT). Major adverse cardiovascular and cerebral events (MACCE) were recorded for a median period of 7 months (range 3 to 37 months) after CABG. Results A total of 359 grafts were analyzed, 186 in TEG-hypercoagulable and 173 in TEG-normocoagulable patients. Frequency of bypass graft occlusion was not significantly different between the two groups (TEG-hypercoagulable=21 and TEG-normocoagulable=18, p=0.9). The number of MACCE was significantly higher in the TEG-hypercoagulable compared to the TEG-normocoagulable group (TEG-hypercoagulable=30% and TEG-normocoagulable=9% p=0.004). Conclusions Hypercoagulability, as evaluated by TEG in patients undergoing CABG is associated with an increased risk of post-surgical thrombembolic events, however not accompanied by augmented coronary bypass graft failure.
Authors:
M Zacho; S Rafiq; H Kelbæk; Pi Johansson; M Bachmann Nielsen; DA Steinbrüchel; K Fuglsang Kofoed
Related Documents :
2651579 - An evaluation of outpatient bone marrow harvesting.
2892989 - Prevention of steroid-induced osteoporosis with (3-amino-1-hydroxypropylidene)-1,1-bisp...
7551659 - The effect of systemic lupus erythematosus and long-term steroid therapy on bone mass i...
23701339 - Randomized clinical trial of the effect of supplemental opioids in procedural sedation ...
18062109 - Sinus floor augmentation with simultaneous implant placement in the severely atrophic m...
9252849 - A 3-year pilot study with 1,25-dihydroxyvitamin d, calcium, and calcitonin for severe o...
14616209 - Spectral doppler and resistive index. a promising tool in ultrasonographic evaluation o...
20851629 - Assessment of long-term outcomes for the stroke doc telemedicine trial.
20220599 - White matter abnormalities as a risk factor for postoperative delirium revealed by diff...
Publication Detail:
Type:  JOURNAL ARTICLE     Date:  2012-12-3
Journal Detail:
Title:  Scandinavian cardiovascular journal : SCJ     Volume:  -     ISSN:  1651-2006     ISO Abbreviation:  Scand. Cardiovasc. J.     Publication Date:  2012 Dec 
Date Detail:
Created Date:  2012-12-4     Completed Date:  -     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  9708377     Medline TA:  Scand Cardiovasc J     Country:  -    
Other Details:
Languages:  ENG     Pagination:  -     Citation Subset:  -    
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Exercise Training and Losartan Improve Endothelial Function in Heart Failure Rats by Different Mecha...
Next Document:  Heart Rate Variability and Red Cell Distribution Width in Patients with Systolic Left Heart Failure.